DK175783B1 - Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser - Google Patents

Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser Download PDF

Info

Publication number
DK175783B1
DK175783B1 DK199001242A DK124290A DK175783B1 DK 175783 B1 DK175783 B1 DK 175783B1 DK 199001242 A DK199001242 A DK 199001242A DK 124290 A DK124290 A DK 124290A DK 175783 B1 DK175783 B1 DK 175783B1
Authority
DK
Denmark
Prior art keywords
group
acid
ascorbate
therapeutically active
hours
Prior art date
Application number
DK199001242A
Other languages
Danish (da)
English (en)
Other versions
DK124290A (da
DK124290D0 (da
Inventor
Richard G Markham
Original Assignee
Oxycal Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/246,504 external-priority patent/US4968716A/en
Priority claimed from PCT/US1989/001642 external-priority patent/WO1990012571A1/en
Application filed by Oxycal Lab Inc filed Critical Oxycal Lab Inc
Publication of DK124290A publication Critical patent/DK124290A/da
Publication of DK124290D0 publication Critical patent/DK124290D0/da
Application granted granted Critical
Publication of DK175783B1 publication Critical patent/DK175783B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK199001242A 1988-09-19 1990-05-18 Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser DK175783B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/246,504 US4968716A (en) 1987-04-10 1988-09-19 Compositions and methods for administering therapeutically active compounds
US24650488 1988-09-19
PCT/US1989/001642 WO1990012571A1 (en) 1989-04-07 1989-04-07 Compositions and methods for administering vitamin c
US8901642 1989-04-07
US8904046 1989-09-15
PCT/US1989/004046 WO1990003167A1 (en) 1988-09-19 1989-09-15 Compositions and methods for administering therapeutically active compounds

Publications (3)

Publication Number Publication Date
DK124290A DK124290A (da) 1990-05-18
DK124290D0 DK124290D0 (da) 1990-05-18
DK175783B1 true DK175783B1 (da) 2005-02-21

Family

ID=22930954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001242A DK175783B1 (da) 1988-09-19 1990-05-18 Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser

Country Status (16)

Country Link
EP (1) EP0417209B1 (no)
JP (1) JP2973365B2 (no)
AT (1) ATE160939T1 (no)
CA (1) CA1341434C (no)
DE (1) DE68928488T2 (no)
DK (1) DK175783B1 (no)
FI (1) FI97950C (no)
HU (1) HU905911D0 (no)
NO (1) NO178056C (no)
NZ (1) NZ230700A (no)
PL (1) PL165416B1 (no)
RO (1) RO108148B1 (no)
RU (1) RU2059410C1 (no)
WO (1) WO1990003167A1 (no)
YU (1) YU47746B (no)
ZA (1) ZA904494B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511396A (en) * 1999-08-30 2003-08-29 Oxycal Lab Inc Compositions containing a metal salt of ascorbic acid for selective cancer chemotherapy
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
FI20095278A0 (fi) 2009-03-18 2009-03-18 Valtion Teknillinen Ksylonihapon valmistus
KR101037125B1 (ko) * 2009-05-14 2011-05-26 계명대학교 산학협력단 바이오에탄올 생산을 위한 바이오매스 전처리법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606903A (en) * 1944-03-29 1952-08-12 Physiological Chemicals Compan Ascorbic acid addition compound of sulfathiazole
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
GB2040164A (en) * 1979-01-31 1980-08-28 Beecham Group Ltd Compositions containing paracetamol
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C

Also Published As

Publication number Publication date
AU621672B2 (en) 1992-03-19
FI902461A0 (fi) 1990-05-18
DK124290A (da) 1990-05-18
FI97950B (fi) 1996-12-13
EP0417209A1 (en) 1991-03-20
NO178056B (no) 1995-10-09
NZ230700A (en) 1992-07-28
DE68928488T2 (de) 1998-04-02
CA1341434C (en) 2003-07-08
DE68928488D1 (de) 1998-01-22
ZA904494B (en) 1991-03-27
RO108148B1 (ro) 1994-02-28
EP0417209A4 (en) 1992-01-08
WO1990003167A1 (en) 1990-04-05
JPH03504502A (ja) 1991-10-03
HU905911D0 (en) 1991-03-28
FI97950C (fi) 1997-03-25
PL165416B1 (pl) 1994-12-30
RU2059410C1 (ru) 1996-05-10
NO902132D0 (no) 1990-05-14
AU4328889A (en) 1990-04-18
ATE160939T1 (de) 1997-12-15
DK124290D0 (da) 1990-05-18
NO178056C (no) 1996-01-17
YU47746B (sh) 1996-01-08
YU117890A (sh) 1993-10-20
NO902132L (no) 1990-05-14
EP0417209B1 (en) 1997-12-10
JP2973365B2 (ja) 1999-11-08

Similar Documents

Publication Publication Date Title
US5070085A (en) Compositions and methods for administering therapeutically active compounds
US4968716A (en) Compositions and methods for administering therapeutically active compounds
CA1328809C (en) Compositions and methods for administering vitamin c
US7375243B2 (en) Method for preparation of amino acid chelate
EP3565806B1 (en) Novel phenyl derivatives
JP5762396B2 (ja) 糖尿病療法の支援のためのα−ケト酸を含有する栄養補助剤
Benevenga et al. Effect of glycine and serine on methionine metabolism in rats fed diets high in methionine
CN102038671B (zh) 包含左卡尼汀和羟苯磺酸盐的药物组合物
US20140342018A1 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
DK175783B1 (da) Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser
CA1133506A (en) Acidic alkali citrate, process for obtaining it and medicament containing it
JP2002121134A (ja) ミネラル塩の生物学的利用能を増大させるためのリポ酸の使用
RU2343911C2 (ru) Усиление метаболизма алкоголя
US8372992B2 (en) Strontium (M) ascorbate, compositions containing same, method for making same and method of using same
KR101826994B1 (ko) 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법
AU621672C (en) Compositions and methods for administering therapeutically active compounds
WO1990012571A1 (en) Compositions and methods for administering vitamin c
Khandare et al. Magnesium hydroxide for protection against fluoride toxicity in rabbits
NO311219B1 (no) Fremgangsmåte for fremstilling av et preparat med forbedret vitamin C-aktivitet
Maevsky et al. Succinate as a mobilization cue
KR940000006B1 (ko) 치료학적으로 활성인 화합물의 조성물.
Hämäläinen et al. Alterations in electrolyte and iron metabolism in the rat in relation to peroral administration of galactitol, mannitol and xylitol
HU211459A9 (hu) Készítmények és eljárások gyógyászatilag aktív vegyületek adagolására Az átmeneti oltalom az 1-7. igénypontokra vonatkozik.
Al-Khayat et al. Chelation of Ambilhar with Calcium and Magnesium
Stokinger Effects of Trace Amounts of Vanadium

Legal Events

Date Code Title Description
PUP Patent expired